APA (7th ed.) Citation

M, L., A, I., C, G., A, V., L, M., F, C., . . . AF, M. (2023). Lethality rescue and long-term amelioration of a citrullinemia type I mouse model by neonatal gene-targeting combined to SaCRISPR-Cas9. Molecular therapy. Methods & clinical development, 31, 101103. https://doi.org/10.1016/j.omtm.2023.08.022

Chicago Style (17th ed.) Citation

M, Lisjak, Iaconcig A, Guarnaccia C, Vicidomini A, Moretti L, Collaud F, Ronzitti G, Zentilin L, and Muro AF. "Lethality Rescue and Long-term Amelioration of a Citrullinemia Type I Mouse Model by Neonatal Gene-targeting Combined to SaCRISPR-Cas9." Molecular Therapy. Methods & Clinical Development 31 (2023): 101103. https://doi.org/10.1016/j.omtm.2023.08.022.

MLA (9th ed.) Citation

M, Lisjak, et al. "Lethality Rescue and Long-term Amelioration of a Citrullinemia Type I Mouse Model by Neonatal Gene-targeting Combined to SaCRISPR-Cas9." Molecular Therapy. Methods & Clinical Development, vol. 31, 2023, p. 101103, https://doi.org/10.1016/j.omtm.2023.08.022.